Product logins

Find logins to all Clarivate products below.


Electrophysiology Mapping and Ablation Devices | Market Insights | Europe | 2023

Following the short-term negative impact of the COVID-19 pandemic, the Europe EP mapping and ablation device market will experience moderate growth through 2031 due to increasing ablation procedure volumes, favorable reimbursement for ablation procedures, and the uptake of premium-priced devices. 

This Medtech 360 Report provides comprehensive data and analysis on the market for EP mapping and ablation devices in Europe from 2019 to 2031.

Related Medtech Insights Reports

Report
Electrophysiology Mapping and Ablation Devices – Market Insights – Europe
The European EP mapping and ablation device market will grow moderately through 2034, driven by the rising prevalence of cardiac arrhythmias, improved access to treatment, advancements in ablation…
Report
Large-Joint Reconstructive Implants – Market Insights – Europe (Supplemental)
The European large-joint reconstructive implant market is poised for long-term growth, driven by the adoption of innovative technologies such as 3-D printed implants and smart implants, as well as…
Report
Neurovascular Devices – Market Insights – Europe
The European neurovascular device market is poised to experience strong growth through 2034. This growth will be driven by the introduction of newly developed technologies, increasing adoption of…
Report
Interventional Cardiology Devices – Market Insights – Europe
The European interventional cardiology device market is highly competitive and poised for growth, driven by increasing PCI volumes for complex CAD cases and the adoption of innovative devices and…
Report
Electrophysiology Mapping and Ablation Devices – Market Insights – Latin America (Supplemental)
The Latin American EP mapping and ablation device market will experience strong growth through 2033, driven by the increasing prevalence of cardiac arrhythmia in Latin American countries, improved…